Leadless Cardiac Pacemaker Coordination for Arrhythmia Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cardiac arrhythmia treatment devices, such as pacemakers and defibrillators, face challenges in effectively distinguishing and treating different types of tachyarrhythmias, leading to inefficient therapy delivery and potential unnecessary shocks to patients.
Innovation Solution
The development of implantable cardioverter-defibrillators (ICDs) that include leadless cardiac pacemakers (LCPs) capable of sensing cardiac signals, delivering tailored anti-tachycardia pacing (ATP) therapy, and coordinating with other devices to differentiate between tachyarrhythmia types, employing specific treatment protocols to optimize therapy effectiveness and conserve battery life.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If implantable devices deliver defibrillation shocks to treat tachyarrhythmias, then life-threatening arrhythmias can be terminated, but unnecessary shocks increase patient harm and reduce therapy effectiveness
Solution Approach 1:
The patent replaces the mechanical/electrical shock delivery system with an electrical stimulation system that delivers pacing pulses. Instead of using defibrillation shocks to terminate tachyarrhythmias, the device uses anti-tachycardia pacing (ATP) with specifically configured pulse trains that can terminate certain tachyarrhythmias without the harmful effects of high-energy shocks. This substitution maintains therapeutic effectiveness while eliminating unnecessary patient harm.
Solution Approach 2:
The patent changes the parameters of electrical stimulation from high-energy defibrillation pulses to lower-energy pacing pulses with specific configurations. The pulse amplitude, width, and timing are optimized to achieve arrhythmia termination through pacing mechanisms rather than shock mechanisms. This parameter transformation allows the device to treat tachyarrhythmias effectively while avoiding the harmful effects associated with high-energy shocks.
2Adaptability or versatility
If multiple implanted devices are used to treat cardiac conditions, then comprehensive therapy coverage is achieved, but device coordination complexity increases
Solution Approach 1:
The patent combines the functions of multiple implanted devices into a single integrated system. The device integrates pacing, defibrillation, and arrhythmia detection capabilities within one implantable cardioverter-defibrillator (ICD), eliminating the need for separate pacemaker and defibrillator devices. This merging reduces coordination complexity while maintaining comprehensive therapy coverage through unified device control and centralized decision-making algorithms.
Solution Approach 2:
The patent creates a universal implantable device that performs multiple functions: bradycardia pacing, tachycardia detection, anti-tachycardia pacing, and defibrillation. This multi-functional device replaces the need for multiple specialized devices, simplifying the overall system architecture and reducing coordination requirements while providing comprehensive cardiac therapy coverage across different arrhythmia types.
3Measurement precision
If implantable devices continuously monitor cardiac signals, then arrhythmia detection accuracy is improved, but energy consumption increases
Solution Approach 1:
The patent implements periodic sampling of cardiac signals rather than continuous monitoring. The device monitors cardiac electrical activity at strategically timed intervals and uses event-triggered detection algorithms that activate monitoring only when arrhythmia suspicion arises. This periodic approach maintains high detection accuracy by capturing critical arrhythmia events while significantly reducing overall power consumption compared to continuous monitoring.
Solution Approach 2:
The patent employs self-service detection algorithms that automatically analyze cardiac signals and determine when intensive monitoring is necessary. The device uses local signal processing and pattern recognition to identify arrhythmia events without requiring continuous high-power processing. This self-service approach enables accurate arrhythmia detection while minimizing energy consumption by activating full monitoring capabilities only when clinically indicated.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Systems and methods for treating cardiac arrhythmias are disclosed. In one embodiment, an SICD comprises two or more electrodes, a charge storage device, and a controller operatively coupled to two or more of the electrodes and the charge storage device. In some embodiments, the controller is configured to monitor cardiac activity of the heart of the patient, detect an occurrence of a cardiac arrhythmia based on the cardiac activity, and determine a type of the detected cardiac arrhythmia from two or more types of cardiac arrhythmias. If the determined type of cardiac arrhythmia is one of a first set of cardiac arrhythmia types, the controller sends an instruction for reception by an LCP to initiate the application of ATP therapy by the LCP. If the determined type of cardiac arrhythmia is not one of the first set cardiac arrhythmia types, the controller does not send the instruction.